Research progress of new antimicrobial agents for drug-resistant pathogenic bacteria / 中华临床感染病杂志
Chinese Journal of Clinical Infectious Diseases
;
(6): 250-265, 2021.
Artículo
en Chino
| WPRIM
| ID: wpr-910890
ABSTRACT
This article reviews the status quo of new antimicrobial agents that have been approved or undergoing phase Ⅱ/Ⅲ clinical trials in last five years at home and abroad, including new β-lactamase inhibitors and their compound preparations, oxazolidinones, tetracyclines, aminoglycosides, glycopeptides, quinolones, new antifungal agents, cyclic lipopeptides and new anti-mycobacterial agents. The antibacterial activities, main mechanisms of drug resistance, and progress of clinical studies of 27 new drugs were introduced to provide a reference for their clinical application.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Journal of Clinical Infectious Diseases
Año:
2021
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS